1-5 of 5
Xiangdong Liu
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Selective inhibition of IDO1 effectively regulates mediators of antitumor immunity

Xiangdong Liu, Niu Shin, Holly K. Koblish, Gengjie Yang, Qian Wang, Kathy Wang, Lynn Leffet, Michael J. Hansbury, Beth Thomas, Mark Rupar, Paul Waeltz, Kevin J. Bowman, Padmaja Polam, Richard B. Sparks, Eddy W. Yue, Yanlong Li, Richard Wynn, Jordan S. Fridman, Timothy C. Burn, Andrew P. Combs, Robert C. Newton, Peggy A. Scherle
Journal: Blood
Blood (2010) 115 (17): 3520–3530.
https://doi.org/10.1182/blood-2009-09-246124
Published: 2010
Journal Articles

Genetic variants in the candidate genes of the apoptosis pathway and susceptibility to chronic myeloid leukemia

Dong Hwan (Dennis) Kim, Wei Xu, Clement Ma, Xiangdong Liu, Katherine Siminovitch, Hans A. Messner, Jeffrey H. Lipton
Journal: Blood
Blood (2009) 113 (11): 2517–2525.
https://doi.org/10.1182/blood-2008-07-169110
Published: 2009
Includes: Supplemental data
Journal Articles

Genetic Variants in the Candidate Genes of the Apoptosis Pathway and Susceptibility to Chronic Myeloid Leukemia

Dong Hwan Kim, MD, PhD, Kyoung Ha Kim, M.D., Myung Hee Chang, M.D., Wei Xu, PhD, Clement Ma, MSc, Xiangdong Liu, Ph.D., Katherine Siminovitch, M.D./Ph.D., Hans A. Messner, M.D./Ph.D, Jeffrey H. Lipton, MD, PhD
Journal: Blood
Blood (2008) 112 (11): 4223.
https://doi.org/10.1182/blood.V112.11.4223.4223
Published: 2008
Journal Articles

Clinical Relevance of Vascular Endothelial Growth Factor (VEGFA) and VEGF Receptor (VEGFR2) Gene Single Nucleotide Polymorphism on the Treatment Outcomes Following Imatinib Mesylate Therapy.

Dong Hwan Kim, MD, PhD, Hee Kyung Ahn, M.D., Wei Xu, PhD, Suzanne Kamel-Reid, PhD, FACMG, Xiangdong Liu, Ph.D., Katherine Siminovitch, M.D./Ph.D., Jeffrey H. Lipton, MD, PhD
Journal: Blood
Blood (2008) 112 (11): 1110.
https://doi.org/10.1182/blood.V112.11.1110.1110
Published: 2008
Journal Articles

Clinical Relevance of a Pharmacogenetic Approach Using Multiple Candidate Gene Polymorphisms To Predict Response and Resistance to Imatinib Mesylate Therapy in Chronic Myeloid Leukemia.

Dong Hwan (Dennis) Kim, MD, PhD, Lakshmi Sriharsha, Wei Xu, Suzanne Kamel-Reid, Xiangdong Liu, Katherine Siminovitch, Hans Messner, Jeffrey Lipton
Journal: Blood
Blood (2007) 110 (11): 737.
https://doi.org/10.1182/blood.V110.11.737.737
Published: 2007